doi:10.1097/GME.0000000000002335
Yes, GLP-1 receptor agonists can be safely used in people with high blood pressure and may produce modest reductions in systolic blood pressure
[DOI] [PubMed] [Google Scholar] Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, et al
It makes sense: GLP-1 receptors are active in the reward centers of the brain, and these medications alter the dopamine response linked to cravings
Individual clinical appropriateness must be determined by a licensed provider based on personal health factors
Recently Lilly announced acquisition of Versanis lead obesity candidate bimagrumab, a monoclonal antibody targeting activin type II receptors to inhibit atrophy and to increase muscle mass (142144)